Literature DB >> 10987310

Human T-cell leukemia virus type I tax activates transcription of the human monocyte chemoattractant protein-1 gene through two nuclear factor-kappaB sites.

N Mori1, A Ueda, S Ikeda, Y Yamasaki, Y Yamada, M Tomonaga, S Morikawa, R Geleziunas, T Yoshimura, N Yamamoto.   

Abstract

Infection by human T-cell leukemia virus type (HTLV) I leads to adult T-cell leukemia and is also associated with the neurodegenerative disease HTLV-I-associated myelopathy/tropical spastic paraparesis. Leukocytes are attracted to sites of inflammation by chemokines. One such chemokine is monocyte chemoattractant protein (MCP)-1, a member of the C-C subfamily of chemokines. We investigated whether HTLV-I infection causes up-regulation of MCP-1, which may in turn cause recruitment of leukocytes to HTLV-I-infected areas. We now report that MCP-1 mRNA levels are elevated in HTLV-I-infected T-cell lines, when compared with uninfected ones. We further confirmed secretion of MCP-1 by HTLV-I-infected T-cell lines. MCP-1 mRNA was also expressed in leukemic cells from patients with adult T-cell leukemia. The 5' transcriptional regulatory region of the MCP-1 gene was activated by the HTLV-I-encoded transactivator Tax in the human T-cell line Jurkat, in which endogenous MCP-1 is induced by Tax. By using site-specific point mutations, we have identified two closely spaced nuclear factor (NF)-kappaB sites, A1 and A2, to be important for Tax-mediated transactivation of the MCP-1 gene. Through the use of an electrophoretic mobility shift assay, we demonstrated that Tax induced NF-kappaB binding to both MCP-1 kappaB sites. This is the first report to demonstrate that Tax can transactivate the MCP-1 gene through the induction of NF-kappaB. Our results thus reveal how Tax disrupts the normally regulated MCP-1 gene and leads to its constitutive expression in HTLV-I-infected cells. These findings may have important implications for our understanding of HTLV-I-associated diseases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10987310

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

1.  Induction of monocyte chemoattractant protein-1 (MCP-1/CCL2) gene expression by human immunodeficiency virus-1 Tat in human astrocytes is CDK9 dependent.

Authors:  Abdelkader Khiati; Olivier Chaloin; Sylviane Muller; Marc Tardieu; Philippe Horellou
Journal:  J Neurovirol       Date:  2010-03       Impact factor: 2.643

2.  Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis.

Authors:  Priya Kannian; Patrick L Green
Journal:  Viruses       Date:  2010-09-24       Impact factor: 5.818

Review 3.  Human T-cell lymphotropic virus: a model of NF-κB-associated tumorigenesis.

Authors:  Zhaoxia Qu; Gutian Xiao
Journal:  Viruses       Date:  2011-06       Impact factor: 5.048

4.  Human T-cell leukemia virus type I infects human lung epithelial cells and induces gene expression of cytokines, chemokines and cell adhesion molecules.

Authors:  Hiromitsu Teruya; Mariko Tomita; Masachika Senba; Chie Ishikawa; Maki Tamayose; Akiko Miyazato; Satomi Yara; Yuetsu Tanaka; Yoichiro Iwakura; Jiro Fujita; Naoki Mori
Journal:  Retrovirology       Date:  2008-09-22       Impact factor: 4.602

5.  Human T lymphotropic virus type-1 p30II alters cellular gene expression to selectively enhance signaling pathways that activate T lymphocytes.

Authors:  Bindhu Michael; Amrithraj M Nair; Hajime Hiraragi; Lei Shen; Gerold Feuer; Kathleen Boris-Lawrie; Michael D Lairmore
Journal:  Retrovirology       Date:  2004-11-23       Impact factor: 4.602

Review 6.  New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma.

Authors:  Kazuyasu Fujii
Journal:  Front Oncol       Date:  2018-06-04       Impact factor: 6.244

Review 7.  Distinct functions of HTLV-1 Tax1 from HTLV-2 Tax2 contribute key roles to viral pathogenesis.

Authors:  Masaya Higuchi; Masahiro Fujii
Journal:  Retrovirology       Date:  2009-12-17       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.